ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT)

SEC filing

ADAPTIVE BIOTECHNOLOGIES CORPORATION

ADPT · CIK 1478320

4 · Dec 8, 2025 · BENZENO SHARON sold 12.60K shares at $16.85/share ($212.4K); exercised options for 12.60K shares

BENZENO SHARON sold 12.60K shares at $16.85/share ($212.4K); exercised options for 12.60K shares

PRIMARY DOCUMENT

xslF345X05/primary_doc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).